Effects of arsenic trioxide (As2O3) on airway remodeling in a Murine model of bronchial asthma

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 12, 2012, Pages 1576-1584

  Xu, Zi ping ^a   Huo, Jian min ^b   Sang, Yu Lan ^b   Kang, Jian ^a   Li, Xue ^c  

^a CHINA MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^c SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

Airway remodeling; Arsenic trioxide; Chronic asthma; Inflammation; Steroid resistant asthma

Indexed keywords

ARSENIC TRIOXIDE; BETA ACTIN; DEXAMETHASONE; GELATINASE B; MESSENGER RNA; OVALBUMIN; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

AIRWAY REMODELING; AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MODEL; FEMALE; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TREATMENT DURATION;

AIRWAY REMODELING; ANIMALS; ARSENICALS; ASTHMA; BRONCHI; DEXAMETHASONE; FEMALE; LUNG; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; OVALBUMIN; OXIDES; RANDOM ALLOCATION; RESPIRATORY FUNCTION TESTS; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84870708444     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/y2012-127     Document Type: Article

References (30)

1. Barnes, P.J. 2003. Pathophysioslogy of allergic inflammation. In Middleton's allergy principles and practices. 6th ed. Mosby, St. Louis, Mo. p. 483.
2. Barnes, P.J. 2004. Corticosteroid resistance in airway disease. Proc. Am. Thorac. Soc. 1(3): 264-268. doi:10.1513/pats.200402-014MS. PMID:16113444.
3. Bateman, E.D., Hurd, S.S., Barnes, P.J., Bousquet, J., Drazen, J.M., FitzGerald, M., et al. 2008. Global strategy for asthma management and prevention: GINA executive summary. Eur. Respir. J. 31(1): 143-178. doi:10.1183/09031936.00138707. PMID:18166595.
4. Benayoun, L., Druilhe, A., Dombret, M.C., Aubier, M., and Pretolani, M. 2003. Airway structural alterations selectively associated with severe asthma. Am. J. Respir. Crit. Care Med. 167(10): 1360-1368. doi:10.1164/rccm.200209-1030OC. PMID:12531777.
5. Boxall, C., Holgate, S.T., and Davies, D.E. 2006. The contribution of transforming growth factor-_ and epidermal growth factor signalling to airway remodelling in chronic asthma. Eur. Respir. J. 27(1): 208-229. doi:10.1183/09031936.06.00130004. PMID:16387953.
6. Burchiel, S.W., Mitchell, L.A., Lauer, F.T., Sun, X., McDonald, J.D., Hudson, L.G., and Liu, K.J. 2009. Immunotoxicity and biodistribution analysis of arsenic trioxide in C57BI/6 mice following a 2-week inhalation exposure. Toxicol. Appl. Pharmacol. 241(3): 253-259. doi:10.1016/j.taap.2009.09.019. PMID:19800901.
7. Chetta, A., Foresi, A., Del Donno, M., Bertorelli, G., Pesci, A., and Olivieri, D. 1997. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest, 111(4): 852-857. doi:10.1378/chest.111.4.852. PMID:9106559.
8. Chu, K.H., Lee, C.C., Hsin, S.C., Cai, B.C., Wang, J.H., and Chiang, B.L. 2010. Arsenic trioxide alleviates airway hyperresponsiveness and eosinophilia in a murine model of asthma. Cell. Mol. Immunol. 7(5): 375-380. doi:10.1038/cmi.2010.26. PMID:20495578.
9. Filosso, P.L., Turello, D., and Magnoni, M.S. 2003. Flogosi cronica e rimodellamento delle vie aeree nell'asma. Importanza dell'intervento precoce [Chronic inflammation and airway remodeling in asthma. Importance of an early treatment]. Minerva Pediatr. 55(4): 323-329. PMID:14608275.
10. Halwani, R., Al-Muhsen, S., and Hamid, Q. 2010. Airway remodeling in asthma. Curr. Opin. Pharmacol. 10(3): 236-245. doi:10.1016/j.coph.2010.06.004. PMID:20591736.
11. Hoshino, M., Takahashi, M., Takai, Y., Sim, J., and Aoike, N. 2001. Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma. Clin. Exp. Allergy, 31(5): 722-730. doi:10.1046/j.1365-2222.2001.01071.x. PMID:11422131.
12. Kelly, E.A., Busse, W.W., and Jarjour, N.N. 2000. Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am. J. Respir. Crit. Care Med. 162(3): 1157-1161. PMID:10988146.
13. Kumar, R.K., Herbert, C., Thomas, P.S., Wollin, L., Beume, R., Yang, M., et al. 2003. Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma. J. Pharmacol. Exp. Ther. 307(1): 349-355. doi:10.1124/jpet.103.053819. PMID:12954795.
14. Lee, C.G., Link, H., Baluk, P., Homer, R.J., Chapoval, S., Bhandari, V., et al. 2004. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat. Med. 10(10): 1095-1103. doi:10.1038/nm1105. PMID:15378055.
15. Lipworth, B.J. 1999. Systemic adverse effects of inhaled corticosteroid therapy. A systematic review and meta-analysis. Arch. Intern. Med. 159(9): 941-955. doi:10.1001/archinte.159.9.941. PMID:10326936.
16. Liu, J., Lu, Y., Wu, Q., Goyer, R.A., and Waalkes, M.P. 2008. Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite. J. Pharmacol. Exp. Ther. 326(2): 363-368. doi:10.1124/jpet.108.139543. PMID:18463319.
17. Mattos, W., Lim, S., Russell, R., Jatakanon, A., Chung, K.F., and Barnes, P.J. 2002. Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. Chest, 122(5): 1543-1552. doi:10.1378/chest.122.5.1543. PMID:12426251.
18. Mauad, T., Bel, E.H., and Sterk, P.J. 2007. Asthma therapy and airway remodeling. J. Allergy Clin. Immunol. 120(5): 997-1009. doi:10.1016/j.jaci.2007.06.031. PMID:17681364.
19. Miller, W.H., Jr, Schipper, H.M., Lee, J.S., Singer, J., and Waxman, S. 2002. Mechanisms of action of arsenic trioxide. Cancer Res. 62(14): 3893-3903. PMID:12124315.
20. Minshall, E.M., Leung, D.Y., Martin, R.J., Song, Y.L., Cameron, L., Ernst, P., and Hamid, Q. 1997. Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 17(3): 326-333. PMID:9308919.
21. Patil, S.U., and Long, A.A. 2010. The usefulness of biomarkers of airway inflammation in managing asthma. Allergy Asthma Proc. 31(4): 259-268. doi:10.2500/aap.2010.31.3350. PMID:20819317.
22. Pitchford, S.C., Riffo-Vasquez, Y., Sousa, A., Momi, S., Gresele, P., Spina, D., and Page, C.P. 2004. Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation. Blood, 103(2): 639-647. doi:10.1182/blood-2003-05-1707. PMID:14504080.
23. Platanias, L.C. 2009. Biological responses to arsenic compounds. J. Biol. Chem. 284(28): 18583-18587. doi:10.1074/jbc.R900003200. PMID:19363033.
24. Tsuchiya, T., Nishimura, Y., Nishiuma, T., Kotani, Y., Funada, Y., Yoshimura, S., and Yokoyama, M. 2003. Airway remodeling of murine chronic antigen exposure model. J. Asthma, 40(8): 935-944. doi:10.1081/JAS-120024594. PMID:14736094.
25. Wang, W.J., and Yang, L. 2007. Effects of dexamethasone on the airway remodeling in asthmatic rats. Journal of Zhengzhou University- Medical Sciences, 42: 130-133.
26. Wenzel, S.E., Balzar, S., Cundall, M., and Chu, H.W. 2003. Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair. J. Allergy Clin. Immunol. 111(6): 1345-1352. doi:10.1067/mai.2003.1464. PMID:12789238.
27. Wilson, J.W., and Li, X. 2001. Vessels: new targets for asthma treatment. Thorax, 56(12): 899-900. doi:10.1136/thorax.56.12.899. PMID:11713349.
28. Zhou, L.-F., Yin, K.-S., and Zhou, Z.-M. 2003. Role of low dosage arsenic trioxide on pulmonary dendritic cells in asthmatic mice. Chin. J. Integr. Med. 9(4): 281-284. [English edition.] doi:10.1007/BF02838615.
29. Zhou, L.F., Yin, K.S., Yang, Y., Huang, M., Zhang, X.L., Wang, T., et al. 2004. Effect of arsenic trioxide on IB-alpha expression and nuclear factor B activation by arsenic trioxide of lung tissue in mice model with asthma. Chinese Journal of Clinical Rehabilitation, 8: 5017-5019. [In Chinese.]
30. Zhou, L.F., Zhu, Y., Cui, X.F., Xie, W.P., Hu, A.H., and Yin, K.S. 2006. Arsenic trioxide, a potent inhibitor of NF-kappaB, abrogates allergen-induced airway hyperresponsiveness and inflammation. Respir. Res. 7(1): 146-157. doi:10.1186/1465-9921-7-146. PMID: 17178007.